Sleep Assessment: The Benefits of Identifying Sleep Disturbance Using a Sleep Questionnaire

Sleep Disturbance Clinical Trial

Official title:

Sleep Assessment: The Benefits of Identifying Sleep Disturbance Using a Sleep Questionnaire

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06074224
• Other study ID #: 2020-05-0067
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2022
• Est. completion date: November 1, 2023

Study information

• Verified date: October 2023
• Source: University of Texas at Austin
• Contact: Sina Ramtin
• Phone: 5124955067
• Email: sina.ramtin[@]austin.utexas.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators are interested in measuring the influence of addressing sleep in the orthopedic setting. This includes assessing patient experience measures (satisfaction with the visit, perceived empathy, communication effectiveness) as well as greater engagement in their healthcare (patient activation). The investigators will also see what factors might be associated with sleep disturbance and if addressing sleep leads to an intervention such as cognitive behavioral therapy.

Description:

All adult (18+ years old) new patients seeing a musculoskeletal specialist will be invited to enroll. For the purposes of this trial, The investigators will include people with lesser degrees of sleep disturbance including anyone with a score greater than 3. For people that are enrolled in the trial, the researcher will record the PSQI score and enter at the first page of survey filled out by the patient after meeting. P The patients in the intervention group will include those for whom their clinician was given their sleep questionnaire result before the visit. The control group will include patients whose clinicians do not view the results, simulating usual care. Patients in both groups will fill out a survey entailing demographics, sleep quality, JSPPPE.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 54
• Est. completion date: November 1, 2023
• Est. primary completion date: November 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 89 Years

Eligibility

Inclusion criteria:

1. Adult patients (18+)

2. Orthopedic new visit

3. Sleep disturbance score > 3

Exclusion criteria:

1. Inability to read.

2. Diminished cognition preventing completion of the questionnaires.

Related Conditions & MeSH terms

• Dyssomnias
• Parasomnias
• Sleep Disturbance

Intervention

Other:
• Sleep assessment score
The patients in the intervention group will include those for whom their clinician was given their sleep questionnaire result before the visit.
• No Score
The patients in the control group will include those for whom their clinician was not given their sleep questionnaire result before the visit.

Locations

Country	Name	City	State
United States	University of Texas Health Austin	Austin	Texas
United States	University of Texas Health Austin (UTHA)	Austin	Texas

Sponsors (1)

Lead Sponsor	Collaborator
University of Texas at Austin

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Jefferson Scale of Patient's Perceptions of Physician Empathy	The Jefferson Scale of Patient's Perceptions of Physician Empathy includes five 7-point scale questions and higher scores indicated greater perceived clinician empathy.	through study completion, an average of 6 months